Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dania A, Monagel"'
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2024)
IntroductionSickle cell disease (SCD) is a common inherited blood disorder characterized by the production of abnormal sickle-shaped red blood cells. SCD can lead to various complications including neurological issues. Early detection and treatment a
Externí odkaz:
https://doaj.org/article/6d32467fbda0459585f9534aa8bcfc47
Autor:
Dania A. Monagel, Shatha S. Algahtani, Lian A. Karawagh, Wafa D. Althubaity, Sara A. Azab, Deena F. Haneef, Naglla Elimam
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundSickle cell nephropathy (SCN) is a significant complication of sickle cell disease (SCD) with an asymptomatic onset in childhood and potential progression to chronic kidney disease (CKD). The clinical findings of SCN include hyposthenuria,
Externí odkaz:
https://doaj.org/article/6595ee9acb09446e8bed7e0d79f9103e
Autor:
Dania A. Monagel, Naglla Alemam, Manar Betar, Fay N. Alnafisi, Dania E. Faidah, Reema E. Aloteibi, Muhammad Khan, Israa A. Malli
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundSickle cell disease (SCD) is a relatively common genetic disorder in Saudi Arabia characterized by the predominance of sickle hemoglobin (HbS). Although multiple supportive care options exist for patients with SCD, hematopoietic stem cell t
Externí odkaz:
https://doaj.org/article/acf06b3e17754837b2c9dbd79bb79d21
Autor:
Dania A. Monagel
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background SAMD9L mutation is linked to the development of myeloid neoplasm. The mutation has a wide range of clinical presentations involving neurological, immunological, and hematological manifestations. Until now, limited data regarding d
Externí odkaz:
https://doaj.org/article/1ebfbd1848a14f91b76a4c4070c442c0
Autor:
Richelle C, Waldner, Gregory M T, Guilcher, Dania A, Monagel, Josephine, Ho, Sunil, Desai, Elizabeth T, Rosolowsky
Publikováno v:
Pediatric Hematology and Oncology. :1-6
Autor:
Dania A. Monagel, Aletani Tala, Alghamdi Arwa, Banjar Sereen, Hakeem Ilana, Hannef Deena, Ahmed Omaima, Elimam Naglla
Publikováno v:
Saudi Medical Journal. 44:498-499
Publikováno v:
Pediatric Blood & Cancer. 69
Pulmonary complications are common in sickle cell disease (SCD). The use of standard myeloablative conditioning regimens may increase the risk of lung injury. We report serial pulmonary function testing (PFT) outcomes in children with SCD who underwe
Autor:
Taryn B. Fay‐McClymont, Dania A. Monagel, Gurpreet Singh, Fiona Schulte, Brian L. Brooks, William S. MacAllister, Naddley Désiré, Aleksandra Mineyko, Marsha Vasserman, Michael T. Leaker, Tony H. Truong, Ravi Shah, Victor A. Lewis, Keith Owen Yeates, Gregory M. T. Guilcher
Publikováno v:
Pediatric Blood & Cancer. 69
Despite advances in the treatment of sickle cell disease (SCD), cerebrovascular and cognitive insults can have lifelong consequences. Hematopoietic cell transplantation (HCT) is an established curative therapy, and recent studies have demonstrated ef
Autor:
Dania A Monagel, Jessica Monteiro, Jennifer Thull-Freedman, Angela Ruzycki, Michael Leaker, MacGregor Steele
Publikováno v:
Paediatricschild health. 27(8)
Objectives Sickle cell disease (SCD) is an inherited multisystem disorder with complications starting in the first year of life. Newborn screening (NBS) can identify infants with SCD and is associated with decreased morbidity and mortality. Variation
Publikováno v:
Transplantation and Cellular Therapy. 28:S341-S342